SavedAdd your journal

Journals / Endokrinolojide Diyalog Dergisi / 2009 / Cilt: 6 - Sayı: 4

Coexistent hurthle cell carcinoma and papillary carcinoma in the same thyroid

Tiroid hurthle hücreli kanser ve papiller kanser birlikteliği

Ayten OĞUZ
Bekir ÇAKIR
Kamile GÜL
Birol KORUKLUOĞLU
Serdar Nevzat UĞRAŞ
Reyhan ERSOY
Pages
236–238
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A micropapillary carcinoma was also detected in the left lobe after complementary thyroidectomy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Existence of more than one thyroid carcinomas in the same gland is rare and known as collision tumor.
📊
Key Findings & Data:Here, we report a 43 year old woman operated for nodular goiter and diagnosed with hurthle cell carcinoma in the right lobe histopathologically.
💡
Conclusion & Impact:A micropapillary carcinoma was also detected in the left lobe after complementary thyroidectomy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Existence of more than one thyroid carcinomas in the same gland is rare and known as collision tumor. Here, we report a 43 year old woman operated for nodular goiter and diagnosed with hurthle cell carcinoma in the right lobe histopathologically. A micropapillary carcinoma was also detected in the left lobe after complementary thyroidectomy.

Özet

Birden fazla tiroid kanserinin aynı zamanda tiroid bezinde oluşumu nadir bir durumdur ve collision tümörü olarak bilinir. Burada 43 yaşında nodüler guatr tanısıyla izlenen bir vakada postoperatif histopatolojik incelemede sağ lobda hurthle hücreli kanser ve tamamlayıcı tiroidektomiyi takiben de sol lobda papiller mikrokarsinom tespit edilen bir vaka sunulmuştur.

🔖

Cite This Article

OĞUZ, A., ÇAKIR, B., GÜL, K., KORUKLUOĞLU, B., UĞRAŞ, S. N., ERSOY, R. (2022). Coexistent hurthle cell carcinoma and papillary carcinoma in the same thyroid. Endokrinolojide Diyalog Dergisi, Cilt: 6 - Sayı: 4, 236–238. https://ajindex.com/articles/500806

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Rosai J. Handling of thyroid follicular patterned lesions. Endocr Pathol 2005;16:279-83
  2. Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988;67:501-8
  3. Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003;13:381-7
  4. LiVolsi VA. Surgical Pathology of the Thyroid. Philadelphia, WB Saunders Co, 1990
  5. Brandwein-Gensier M, Urken M, Wang B. Collision tumor of the thyroid: a case report of metastatic liposarcoma plus papillary thyroid carcinoma. Head & Neck 2004;26:637-41
  6. Rossi S, Fugazzola L, De Pasquale L, et al. Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour: report of three cases with molecular analysis and review of the literature. Endocrine-Related Cancer 2005;12:281-9
  7. Wu CJ, Chen HL, Song YM, Sheu WH, Chen SH. Mixed medullary-follicular carcinoma and papillary carcinoma of the same thyroid. Intern Med 1998;37:955-7
  8. Burguera B, Gharib H. Thyroid incidentalomas. Prevalance, diagnosis, significance and management. Endocrin Metab Clin North Am 2000;29:187-203
  9. Erbil Y, Bozbora A, Barbaros U, Özbey N, Kapran Y, Özarmağan S. Papiller mikrokarsinomlara yaklaşım. Çağdaş Cerrahi Dergisi 2003;17:30-5
  10. Kimura ET, Nikiforova MN, Zhu Z, et al. High prevalence of BRAF mutations in thyroid cancer:genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 2003;63:1454-7
  11. Nishiyama RH. Overview of surgical pathology of the thyroid gland. World J Surg 2000;24:898-906
  12. Slough CM, Randolph GW. Workup of well-differentiated thyroid carcinoma. Cancer Control 2006;13:99-105
  13. Arganini M, Behar R, Wu TC, et al. Hürthle cell tumors: a twenty-five-year experience. Surgery 1986;100:1108-15
  14. Stojadinovic A, Hoos A, Ghossein RA, et al. Hürthle cell carcinoma: a 60-year experience. Ann Surg Oncol 2002;9:197-203
  15. Chiappetta G, Toti P, Cetta F, et al. The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hürthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions. J Clin Endocrinol and Metab 2002;87:364-9
  16. Cheung CC, Ezzat S, Raymar L, Freeman JL, Asa SL. Molecular basis of Hurthle cell papillary thyroid carcinoma. J Clin Endocrinol Metab 20